FDA seeks more data on Novartis' meningitis vaccine Menveo

07/1/2009 | Reuters

Novartis said the FDA asked for more data on the clinical and the Chemistry Manufacturing and Control sections of its application for meningitis vaccine Menveo. The drugmaker said it might be able to fully address the concerns this year because the FDA did not recommend additional clinical trials.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC